Boston Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-99,229
Closed -$1.75M 680
2019
Q4
$1.75M Sell
99,229
-35,809
-27% -$607K ﹤0.01% 515
2019
Q3
$2.39M Sell
135,038
-2,598
-2% -$52.6K ﹤0.01% 462
2019
Q2
$2.94M Sell
137,636
-19,185
-12% -$402K ﹤0.01% 469
2019
Q1
$3.73M Sell
156,821
-9,660
-6% -$220K ﹤0.01% 447
2018
Q4
$3.27M Buy
+166,481
New +$2.97M ﹤0.01% 469

Other funds holding EXEL

Boston Partners's EXEL Position: Q1 2020 in Review

Boston Partners sold out of Exelixis (EXEL) in Q1 2020, closing a stake of 99,229 shares — an estimated $1.75M sold.

Boston Partners first reported a position in EXEL in Q4 2018 and held it in 5 quarters. The position peaked at $3.73M in Q1 2019. 337 funds tracked by Wall St. Rank hold EXEL as of Q1 2020.

  • Boston Partners reported no remaining Exelixis position as of Q1 2020 after selling out during the quarter.
  • Boston Partners sold 99,229 Exelixis shares in Q1 2020, an estimated $1.75M.
  • Boston Partners first reported a position in Exelixis in Q4 2018 and held it in 5 quarters.
  • Boston Partners's Exelixis position peaked at $3.73M in Q1 2019.
  • 337 funds tracked by Wall St. Rank held Exelixis as of Q1 2020.

Based on Boston Partners's 13F filing for Q1 2020, filed 13 May 2020.